Physician profile
Hannah E Wheaton
NPI 1356895759
$5,874.91
in general payments reported to CMS, 2019-2025
11 companies · $1,781 in 2025
The $1,781 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.09 · 2023: $3,413 · 2024: $664 · 2025: $1,781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,332 · Food and Beverage: $1,805 · Travel and Lodging: $1,623 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,332.00 |
| Food and Beverage | $1,805.12 |
| Travel and Lodging | $1,622.70 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunogen, INC. | $3,089.57 | 2023 | Elahere |
| Corcept Therapeutics | $1,096.77 | 2025 | |
| Eisai INC. | $355.60 | 2023-2025 | |
| Abbott Laboratories | $338.38 | 2025 | Cardiomems |
| Glaxosmithkline, LLC. | $328.71 | 2023-2025 | Jemperli, Zejula |
| Seagen INC. | $164.00 | 2023-2025 | Tivdak |
| Merck Sharp & Dohme LLC | $134.94 | 2022-2025 | Lynparza, Keytruda |
| Astrazeneca Pharmaceuticals LP | $124.26 | 2024 | Lynparza |
| Pfizer INC. | $118.44 | 2025 | |
| Abbvie INC. | $99.21 | 2024 | |
| Novartis Pharmaceuticals Corporation | $25.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Wheaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.